search
Back to results

A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital

Primary Purpose

Postpartum Depression, Postpartum Anxiety

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ROSE
Standard of Care
Sponsored by
University of Rochester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postpartum Depression

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Viable pregnancy between 20 weeks 0 days and 35 weeks 0 days gestation at the time of enrollment
  • Anticipated admission to the hospital for >5 days due to pregnancy complication requiring hospital observation
  • Age > 18 years
  • Planned hospitalization at Strong Memorial Hospital through the duration of antepartum course
  • Planned delivery at Strong Memorial Hospital

Exclusion Criteria:

  • Fetal demise in utero
  • Inability to give informed consent secondary to intellectual capacity
  • English is not primary language used to communicate
  • Currently incarcerated
  • Age < 18 years
  • Planned antepartum hospitalization at another institution
  • Planned delivery at another institution
  • Actively suicidal or in need of acute psychiatric care

Sites / Locations

  • Strong Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

ROSE Intervention

Standard of Care

Arm Description

Outcomes

Primary Outcome Measures

Subject-reported in-hospital distress
Hospital distress will be measured using the Depression, Anxiety and Stress Scale-21 (DASS-21) Stress subscale. Stress subscale ranges from 0 to 42 with higher scores indicating worse outcome.
Subject-reported depressive symptom severity
Depressive symptom severity will be measured using the Edinburgh Postnatal Depression Scale (EPDS). The scale ranges from 0-30 with higher scores indicating worse outcome.
Subject-reported anxiety symptom severity
Anxiety symptom severity will be measured using the General Anxiety Disorder-7 (GAD-7) measurement scale. The scale ranges from 0 to 21 with higher scores indicating worse outcome.
Clinical diagnosis of depression
Diagnosis of depression will be made using the Mini International Neuropsychiatric Interview (M.I.N.I) brief structured diagnostic interview which explores, in a standardized way, the main psychiatric disorders of Axis I of the DSM-IV TR. Only modules A and B (Major depressive episode and dysthymia) will be used. This structured interview contains questions with binary answers, with Yes indicating worse outcome.

Secondary Outcome Measures

Full Information

First Posted
January 7, 2022
Last Updated
June 9, 2022
Sponsor
University of Rochester
Collaborators
Mae Stone Goode Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05225025
Brief Title
A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital
Official Title
A Pilot Trial of the ROSE Postpartum Depression Prevention Intervention in Antepartum Patients Admitted to High-risk Obstetrics Unit
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
July 5, 2021 (Actual)
Primary Completion Date
May 2, 2022 (Actual)
Study Completion Date
May 2, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Rochester
Collaborators
Mae Stone Goode Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is a pilot, single-center, randomized controlled trial. It will determine feasibility and acceptability of an evidence-based intervention for prevention of postpartum depression with antepartum patients on a high-risk obstetric unit, determine what adaptations may be needed for an inpatient population determine what retention strategies are most successful and acceptable for this patient population estimate the effect size of an intervention for in-hospital distress, anxiety and depression estimate the effect size of an intervention to reduce the risk of a post-partum depression diagnosis or depressive symptoms.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postpartum Depression, Postpartum Anxiety

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
45 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ROSE Intervention
Arm Type
Experimental
Arm Title
Standard of Care
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
ROSE
Intervention Description
The ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns) program is an evidence-based intervention that has been proven to reduce cases of post-partum depression among low-income and racially and ethnically diverse women. ROSE is administered to pregnant women in small group settings, typically in the same location that prenatal care is being provided (in this study, a hospital setting). It is divided into four 90-minute group sessions and teaches interpersonal psychotherapy-based skills that mitigate identified risk factors for PPD such as social support, stress management skills and communication. ROSE curriculum will be implemented using groups in a continuous cycle, with patients entering into the intervention curriculum at the time of their enrollment and continuing through until all 4 total sessions have been accomplished.
Intervention Type
Other
Intervention Name(s)
Standard of Care
Intervention Description
Usual hospital care with no behavioral intervention
Primary Outcome Measure Information:
Title
Subject-reported in-hospital distress
Description
Hospital distress will be measured using the Depression, Anxiety and Stress Scale-21 (DASS-21) Stress subscale. Stress subscale ranges from 0 to 42 with higher scores indicating worse outcome.
Time Frame
14 days
Title
Subject-reported depressive symptom severity
Description
Depressive symptom severity will be measured using the Edinburgh Postnatal Depression Scale (EPDS). The scale ranges from 0-30 with higher scores indicating worse outcome.
Time Frame
6 weeks postpartum
Title
Subject-reported anxiety symptom severity
Description
Anxiety symptom severity will be measured using the General Anxiety Disorder-7 (GAD-7) measurement scale. The scale ranges from 0 to 21 with higher scores indicating worse outcome.
Time Frame
6 weeks postpartum
Title
Clinical diagnosis of depression
Description
Diagnosis of depression will be made using the Mini International Neuropsychiatric Interview (M.I.N.I) brief structured diagnostic interview which explores, in a standardized way, the main psychiatric disorders of Axis I of the DSM-IV TR. Only modules A and B (Major depressive episode and dysthymia) will be used. This structured interview contains questions with binary answers, with Yes indicating worse outcome.
Time Frame
6 weeks postpartum
Other Pre-specified Outcome Measures:
Title
satisfaction with ROSE behavioral health intervention
Description
Satisfaction score will be measured using the Client Satisfaction Questionnaire-8 (CSQ-8). The scores range from 8-32, with greater satisfaction indicated by higher scores.
Time Frame
14 days and 6 weeks postpartum
Title
self-reported mother-infant bonding
Description
Mother-infant bonding will be assessed over four domains by the Postpartum Bonding Questionnaire (PBQ). Scores range from 0-125, with worse outcome indicated by higher scores.
Time Frame
6 weeks postpartum
Title
self-reported functional status
Description
Functional status will be assessed using the Inventory of Functional Status After Childbirth (IFSAC) measure. Scores range from 36-144, with higher scores indicating better outcome.
Time Frame
6 weeks postpartum
Title
percentage of eligible subjects who enrolled in the study
Time Frame
baseline
Title
percentage of enrolled subjects who completed all inpatient study activities
Time Frame
14 days
Title
percentage of enrolled subjects who completed all inpatient plus outpatient study activities
Time Frame
6 weeks postpartum

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Viable pregnancy between 20 weeks 0 days and 35 weeks 0 days gestation at the time of enrollment Anticipated admission to the hospital for >5 days due to pregnancy complication requiring hospital observation Age > 18 years Planned hospitalization at Strong Memorial Hospital through the duration of antepartum course Planned delivery at Strong Memorial Hospital Exclusion Criteria: Fetal demise in utero Inability to give informed consent secondary to intellectual capacity English is not primary language used to communicate Currently incarcerated Age < 18 years Planned antepartum hospitalization at another institution Planned delivery at another institution Actively suicidal or in need of acute psychiatric care
Facility Information:
Facility Name
Strong Hospital
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital

We'll reach out to this number within 24 hrs